Alcohol-associated Liver Disease

Questions discussed in this category

In what cases do you use baclofen for alcohol use disorder?

3 Answers available

With the growth of non-alcoholic beverages (e.g., NA beer, liquor, etc), how do you approach a patient's consumption of these products in the setting of alcohol related liver disease?

2 Answers available

What role is there for use of ELF in patients with active alcohol use disorder for which Fibroscan is not able to give a reliable assessment of fibrosis due to ongoing active alcohol use?

1 Answer available

What factors into your choice to use craving-related medications (e.g., baclofen, naltrexone, acamprosate, etc.) in the management of alcohol use disorder?

Do you continue them after a liver transplant?

2 Answers available

In patients with Met-ALD, how do you approach their treatment plan?

Do you tackle the alcohol first over the metabolic comorbidities?

1 Answer available

How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?

1 Answer available

How do you approach a conversation with a patient with a markedly positive PETH (>200 ug/L) who is insistent that they do not consume any alcohol?

Do you perform any subsequent testing?

1 Answer available

In what clinical scenario would larsucosterol be considered as therapy in alcohol related hepatitis?

1 Answer available

How do you balance infection risk versus therapeutic benefit of steroid tapers when treating patients with alcohol related hepatitis?

1 Answer available

How do you utilize the Sustained Alcohol Use Post-Liver Transplant (SALT) score on surveillance for alcohol use for patients after liver transplant?

1 Answer available

Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?

2 Answers available

Papers discussed in this category

Frontiers in psychiatry, 2018 Oct 08

Tailored-Dose Baclofen in the Management of Alcoholism: A Retrospective Study of 144 Outpatients Followed for 3 Years in a French General Practice.

Pharmacoepidemiology and drug safety, 2018 Sep 25

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.

The Journal of clinical psychiatry, 2020 Aug 04

Individualized, High-Dose Baclofen for Reduction in Alcohol Intake in Persons With High Levels of Consumption.

Drug and alcohol dependence, 2024 Sep 07

Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

JAMA psychiatry, 2025 Apr 01

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.

BMJ open gastroenterology, 2025 Aug 04

Enhanced liver fibrosis test facilitates stratification of people with alcohol use disorder in primary care.

Related Topics